Adeuyan, O., Magro, C. M., Trager, M. H., Gordon, E. R., Lapolla, B. A., Schreidah, C. M., Fahmy, L. M., & Geskin, L. J. (2024). Plasma cell and neutrophil enriched neovascularization with granulomatous lymphangitis in POEMS syndrome. JAAD Case Reports, 49, 125–128. https://doi.org/10.1016/j.jdcr.2024.03.025

Zonozi, R., Aqeel, F., Le, D., Cortazar, F. B., Thaker, J., Zabala Ramirez, M. J., Sattui Cortes, S. E., Attieh, R. M., Chung, M., Bulbin, D. H., Shaikh, A., Guaman, K., Ford, J., Diffie, C., Gewurz-Singer, O., Sauvage, G., Jeyabalan, A., Geara, A., Ayoub, I., … Geetha, D. (2024). Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Kidney International Reports, 9(6), 1783–1791. https://doi.org/10.1016/j.ekir.2024.03.022

Sethi, S., Beck, L. H., Glassock, R. J., Haas, M., De Vriese, A. S., Caza, T. N., Hoxha, E., Lambeau, G., Tomas, N. M., Madden, B., Debiec, H., D’Agati, V. D., Alexander, M. P., Amer, H., Appel, G. B., Barbour, S. J., Caravaca-Fontan, F., Cattran, D. C., Casal Moura, M., … Fervenza, F. C. (2023). Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification. Mayo Clinic Proceedings, 98(11), 1671–1684. https://doi.org/10.1016/j.mayocp.2023.08.006

Oliva-Damaso, N., & Bomback, A. S. (2023). Intravenous Methylprednisolone in Induction Therapy for ANCA-Associated Vasculitis: How Low Can We Go? Kidney360, 4(9), e1199–e1200. https://doi.org/10.34067/kid.0000000000000257

Cortazar, F. B., Cerda, J., Dhanani, R., Roglieri, J., & Santoriello, D. (2023). Avacopan in Patients With Rapidly Progressive Glomerulonephritis Requiring Dialysis. Kidney International Reports, 8(8), 1687–1691. https://doi.org/10.1016/j.ekir.2023.05.017

Perkovic, V., Barratt, J., Radhakrishnan, J., Rizk, D., Trimarchi, H., Khawaja, Z., Leiske, J., Sorensen, B., King, A., Jones-Burton, C., & Campbell, K. (2023). #4333 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BION-1301 IN ADULTS WITH IGA NEPHROPATHY. Nephrology Dialysis Transplantation, 38(Supplement_1). https://doi.org/10.1093/ndt/gfad063c_4333

Zubidat, D., Madden, B., Kudose, S., Nasr, S. H., Nardelli, L., Fervenza, F. C., & Sethi, S. (2023). Heterogeneity of Target Antigens in Sarcoidosis-Associated Membranous Nephropathy. Kidney International Reports, 8(6), 1213–1219. https://doi.org/10.1016/j.ekir.2023.03.019

Mariani, L. H., Eddy, S., AlAkwaa, F. M., McCown, P. J., Harder, J. L., Nair, V., Eichinger, F., Martini, S., Ademola, A. D., Boima, V., Reich, H. N., El Saghir, J., Godfrey, B., Ju, W., Tanner, E. C., Vega-Warner, V., Wys, N. L., Adler, S. G., Appel, G. B., … Kretzler, M. (2023). Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis. Kidney International, 103(3), 565–579. https://doi.org/10.1016/j.kint.2022.10.023

Batal, I., Khairallah, P., Weins, A., Andeen, N. K., & Stokes, M. B. (2023). The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1124249

Ycaza Zurita, M. G., Martínez Ruiz, G. E., Castillo Cedeño, E. E., & Orozco Coello, S. D. (2023). Glomerulonefritis necrotizante. RECIAMUC, 7(1), 61–67. https://doi.org/10.26820/reciamuc/7.(1).enero.2023.61-67

Floege, J., Gibson, K. L., Praga, M., Radhakrishnan, J., Reich, H. N., Schreuder, M. F., Wetzels, J. F., Tesař, V., Vivarelli, M., Biechele, S., & Tonelli, M. (2022). Diagnosis and Treatment of Patients With Focal Segmental Glomerulosclerosis/Steroid-Resistant Nephrotic Syndrome: A Delphi Survey. Kidney International Reports, 7(9), 2081–2085. https://doi.org/10.1016/j.ekir.2022.06.010